The number of maternal deaths and maternal mortality rates for selected causes, 2000 to most recent year.

Maternal mortality ratio is defined as the number of female deaths due to obstetric causes (ICD-10 codes: A34, O00-O95, O98-O99) while pregnant or within 42 days of termination of pregnancy. The maternal mortality ratio indicates the likelihood of a pregnant person dying of obstetric causes. It is calculated by dividing the number of deaths among birthing people attributable to obstetric causes in a calendar year by the number of live births registered for the same period and is presented as a rate per 100,000 live births. The number of live births used in the denominator approximates the population of pregnant and birthing people who are at risk. Data are not presented for geographies with number of maternal deaths less than 11.Compared to other high-income countries, women in the US are more likely to die from childbirth or problems related to pregnancy. In addition, there are persistent disparities by race and ethnicity, with Black pregnant persons experiencing a much higher rate of maternal mortality compared to White pregnant persons. Improving the quality of medical care for pregnant individuals before, during, and after pregnancy can help reduce maternal deaths.For more information about the Community Health Profiles Data Initiative, please see the initiative homepage.

Maternal Mortality Ratio per 100,000

The maternal mortality rate in Australia in 2018 was 5 deaths per 100,000 women giving birth.

From 2009 to 2018, there were 251 women reported to have died during pregnancy or within 42 days of the end of pregnancy and a maternal mortality rate of 6.7 deaths per 100,000 women giving birth.

Further information can be found here: https://www.aihw.gov.au/reports/mothers-babies/maternal-deaths-in-australia/data

In 2023, non-Hispanic Black women had the highest rates of maternal mortality among select races/ethnicities in the United States, with 50.3 deaths per 100,000 live births. The total maternal mortality rate in the U.S. at that time was 18.6 per 100,000 live births, a decrease from a rate of almost 33 in 2021. This statistic presents the maternal mortality rates in the United States from 2018 to 2023, by race and ethnicity.

Time series data for the statistic Maternal mortality ratio (modeled estimate, per 100,000 live births) and country Malta. Indicator Definition:Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant or within 42 days of pregnancy termination per 100,000 live births. The data are estimated with a regression model using information on the proportion of maternal deaths among non-AIDS deaths in women ages 15-49, fertility, birth attendants, and GDP measured using purchasing power parities (PPPs).The indicator "Maternal mortality ratio (modeled estimate, per 100,000 live births)" stands at 8.00 as of 12/31/2023, the lowest value since 12/31/2018. Regarding the One-Year-Change of the series, the current value constitutes a decrease of -20.00 percent compared to the value the year prior.The 1 year change in percent is -20.00.The 3 year change in percent is -20.00.The 5 year change in percent is -11.11.The 10 year change in percent is 14.29.The Serie's long term average value is 12.56. It's latest available value, on 12/31/2023, is 36.33 percent lower, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/2013, to it's latest available value, on 12/31/2023, is +14.29%.The Serie's change in percent from it's maximum value, on 12/31/1985, to it's latest available value, on 12/31/2023, is -61.90%.

Time series data for the statistic Maternal mortality ratio (modeled estimate, per 100,000 live births) and country Albania. Indicator Definition:Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant or within 42 days of pregnancy termination per 100,000 live births. The data are estimated with a regression model using information on the proportion of maternal deaths among non-AIDS deaths in women ages 15-49, fertility, birth attendants, and GDP measured using purchasing power parities (PPPs).The indicator "Maternal mortality ratio (modeled estimate, per 100,000 live births)" stands at 7.00 as of 12/31/2023, the lowest value at least since 12/31/1986, the period currently displayed. Regarding the One-Year-Change of the series, the current value constitutes a decrease of -12.50 percent compared to the value the year prior.The 1 year change in percent is -12.50.The 3 year change in percent is 0.0.The 5 year change in percent is 0.0.The 10 year change in percent is -30.00.The Serie's long term average value is 16.41. It's latest available value, on 12/31/2023, is 57.34 percent lower, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/2018, to it's latest available value, on 12/31/2023, is +0.0%.The Serie's change in percent from it's maximum value, on 12/31/1985, to it's latest available value, on 12/31/2023, is -81.58%.

The fifth round of the Global Reproductive, Maternal, Newborn, Child and Adolescent Health Policy Survey was conducted in 2018-2019. For this survey, the questionnaire was administered online to each member state via World Health Organization (WHO) regional offices. Each WHO country office was asked to coordinate completion of the survey with the Ministry of Health and other UN partners. Respondents from each country shared original source documents including national policies, strategies, laws, guidelines, reports that are relevant to the areas of sexual and reproductive health, maternal and newborn health, child health, adolescent health, gender-based violence and cross-cutting issues. Cross cutting issues include policies, guidelines and legislation for human right to healthcare, financial protection, and quality of care.The WHO Maternal and Newborn Health page can be found here, and the WHO data can also be accessed on their data portal page, here. Maternal and Newborn Health Policy data, provided by the WHO, show the below data attributes for countries that have an International Confederation of Midwives (ICM) membership and have completed the required surveys. Essential Medicines List Includes: Magnesium sulfate for use during pregnancy, childbirth and postpartum careOxytocin for use during pregnancy, childbirth and postpartum careMisoprostol tablets for use during pregnancy, childbirth and postpartum careAmpicillin or Amoxicillin injections for use during pregnancy, childbirth and postpartum careGentamicin injectionMetronidazole injectionProcaine penicillin injectionBenzathine penicillin injectionDexamethasone injectionChlorhexidineCeftriaxoneIntravenous tranexamic acidNational list of Commodities Includes:Obstetric ultrasound machineSelf-inflating bag with neonatal and paediatric masks of different sizes and valves Oxygen supplyVaccuum aspiratorHealth Access Policy: User fee exemptions for antenatal care services for women of reproductive ageUser fee exemptions for normal childbirth services for women of reproductive ageUser fee exemptions for postnatal care for mothersUser fee exemptions for postnatal care for newbornsMaternal and Newborn Health Policies: Policy/legislation on free access to health services for newborns (0-4 weeks)Policy on free access to health services for pregnant womenNational policy on childbirthNational policy/guideline on right of every women to have access to skilled care at childbirthNational policy on postnatal care for mothers and newbornsNational policy on management of low birth weight and preterm newbornsNational standards for management of newborn infants with severe illnessContinuous professional education system in place for primary health-care clinicians and/or nurses to receive specific training for maternal and newborn healthNational policy on regulation of midwifery care providers based on ICMNational policy recommending midwife-led care for pregnancyNational policy recommending midwife-led care for childbirthNational policy recommending midwife-led care for the postnatal periodNational policy/law on maternal death notification within 24 hoursNational policy/law on maternal death reviewNational panel to review maternal deathsFrequency of meetings of national panel to review maternal deathsNational policy/law to review stillbirthsFacility stillbirth review process in placeNational policy/law to review neonatal deathsFacility neonatal death review process in placeThis data set is just one of the many datasets on the Global Midwives Hub, a digital resource with open data, maps, and mapping applications (among other things), to support advocacy for improved maternal and newborn services, supported by the International Confederation of Midwives (ICM), UNFPA, WHO, and Direct Relief.

Abstract Objective To determine the profile of maternal deaths occurred in the period between 2000 and 2019 in the Hospital de Clínicas de Porto Alegre (HCPA, in the Portuguese acronym) and to compare it with maternal deaths between 1980 and 1999 in the same institution. Methods Retrospective study that analyzed 2,481 medical records of women between 10 and 49 years old who died between 2000 and 2018. The present study was approved by the Ethics Committee (CAAE 78021417600005327). Results After reviewing 2,481 medical records of women who died in reproductive age, 43 deaths had occurred during pregnancy or in the postpartum period. Of these, 28 were considered maternal deaths. The maternal mortality ratio was 37.6 per 100,000 live births. Regarding causes, 16 deaths (57.1%) were directly associated with pregnancy, 10 (35.1%) were indirectly associated, and 2 (7.1%) were unrelated. The main cause of death was hypertension during pregnancy (31.2%) followed by acute liver steatosis during pregnancy (25%). In the previous study, published in 2003 in the same institution4, the mortality rate was 129 per 100,000 live births, and most deaths were related to direct obstetric causes (62%). The main causes of death in this period were due to hypertensive complications (17.2%), followed by postcesarean infection (16%). Conclusion Compared with data before the decade of 2000, there was an important reduction in maternal deaths due to infectious causes.

Time series data for the statistic Maternal mortality ratio (modeled estimate, per 100,000 live births) and country North Macedonia. Indicator Definition:Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant or within 42 days of pregnancy termination per 100,000 live births. The data are estimated with a regression model using information on the proportion of maternal deaths among non-AIDS deaths in women ages 15-49, fertility, birth attendants, and GDP measured using purchasing power parities (PPPs).The indicator "Maternal mortality ratio (modeled estimate, per 100,000 live births)" stands at 3.00 as of 12/31/2023. Regarding the One-Year-Change of the series, the current value is equal to the value the year prior.The 1 year change in percent is 0.0.The 3 year change in percent is -57.14.The 5 year change in percent is 0.0.The 10 year change in percent is -40.00.The Serie's long term average value is 9.26. It's latest available value, on 12/31/2023, is 67.59 percent lower, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/2018, to it's latest available value, on 12/31/2023, is +0.0%.The Serie's change in percent from it's maximum value, on 12/31/1985, to it's latest available value, on 12/31/2023, is -82.35%.

Care-seeking among pregnancy-related death cases who sought formal care (n = 96) in Jember District, 2017–2018.

ObjectiveTo identify the pregnancy outcomes and risk factors of critically ill pulmonary hypertension (PH) patients with intensive care unit (ICU) admission.MethodsThe multicenter, retrospective cohort study was performed on 60,306 parturients from January 2013 to December 2018 in China. Diagnosis of PH was based on the estimation of systolic pulmonary arterial pressure (sPAP) via echocardiography. Patients were stratified by sPAP into three groups, mild (30–50 mmHg), moderate (51–70 mmHg), and severe (>70 mmHg). The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of in-hospital death, heart failure, and sustained arrhythmias requiring treatment. The secondary outcome was fetal adverse clinical events (FACE), a composite of fetal/neonatal death, prematurity, small birth weight, and fetal distress.ResultsA total of 181 pregnant patients were enrolled, including 101 patients with mild PH, 31 with moderate PH, and 49 with severe PH. The maternal median age was 32 (27, 35) years and 37% were nulliparous. The MACE occurred in 59 (59/181, 32.6%) women, including in-hospital death in 13 (13/181, 7.2%), heart failure in 53 (53/181, 29.3%), and sustained arrhythmias in 7 (7/181, 3.9%). The incidence of FACE was as high as 66.3% (120/181). Compared with mild and moderate PH patients, patients with severe PH had a significantly higher mortality rate (22.4 vs. 1.51%, P < 0.001) and MACE incidence (51.0 vs. 25.8%, P = 0.001). Although the incidence of FACE in severe PH was slightly higher than that in mild to moderate PH, there was no significant difference (69.4 vs. 65.1%, P = 0.724). PH complicated with left heart disease (OR = 4.365, CI: 1.306–14.591), elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) level (OR = 1.051, CI:1.015–1.088), and sPAP level estimated by echocardiography (OR = 1.021; CI: 1.003–1.040) were independently associated with MACE in multivariable regression (P < 0.05). Increased risk of FACE was noted for PH patients combined with eclampsia/preeclampsia (OR = 6.713; CI: 1.806–24.959).ConclusionThe incidence of MACE and FACE remained high in critically ill pregnant patients with PH, particularly moderate and severe PH in China. Further studies are warranted to identify subsets of women with PH at lower pregnant risks and seek more effective therapy to improve pregnancy outcomes.

Sociodemographic and obstetric characteristics of the participants.